| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Breakthrough technology for in-hospital glucose monitoring
|
Kerr, David
|
|
|
10 |
5 |
p. 304-306
|
artikel
|
| 2 |
Caring for people with diabetes and non-communicable diseases in Ukraine: a humanitarian emergency
|
Maystruk, Galyna
|
|
|
10 |
5 |
p. 308
|
artikel
|
| 3 |
Dapagliflozin in young people with type 2 diabetes
|
Tommerdahl, Kalie L
|
|
|
10 |
5 |
p. 303-304
|
artikel
|
| 4 |
Diabetes in Pakistan: addressing the crisis
|
Bhutta, Zulfiqar A
|
|
|
10 |
5 |
p. 309-310
|
artikel
|
| 5 |
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
|
Tamborlane, William V
|
|
|
10 |
5 |
p. 341-350
|
artikel
|
| 6 |
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
van Dijk, Myrthe M
|
|
|
10 |
5 |
p. 322-329
|
artikel
|
| 7 |
Levothyroxine treatment in euthyroid women positive for thyroid peroxidase antibodies and recurrent pregnancy loss
|
Korevaar, Tim I M
|
|
|
10 |
5 |
p. 299-301
|
artikel
|
| 8 |
Long COVID: the elephant in the room
|
The Lancet Diabetes & Endocrinology,
|
|
|
10 |
5 |
p. 297
|
artikel
|
| 9 |
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
|
Ostadal, Petr
|
|
|
10 |
5 |
p. 330-340
|
artikel
|
| 10 |
Methodological considerations in D-health cancer mortality results
|
Egger, Sam
|
|
|
10 |
5 |
p. 307
|
artikel
|
| 11 |
Methodological considerations in D-health cancer mortality results – Authors' reply
|
Neale, Rachel E
|
|
|
10 |
5 |
p. 307-308
|
artikel
|
| 12 |
Obesity in children and adolescents: epidemiology, causes, assessment, and management
|
Jebeile, Hiba
|
|
|
10 |
5 |
p. 351-365
|
artikel
|
| 13 |
Rising diabetes diagnosis in long COVID
|
Narayan, K M Venkat
|
|
|
10 |
5 |
p. 298-299
|
artikel
|
| 14 |
Risks and burdens of incident diabetes in long COVID: a cohort study
|
Xie, Yan
|
|
|
10 |
5 |
p. 311-321
|
artikel
|
| 15 |
Targeting PCSK9 inhibitors to those who will benefit most
|
Turner, Traci A
|
|
|
10 |
5 |
p. 301-303
|
artikel
|
| 16 |
The relevance of T3 in the management of hypothyroidism
|
Salvatore, Domenico
|
|
|
10 |
5 |
p. 366-372
|
artikel
|
Tijdschrift beschrijving